Corrigendum to "Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma".
Harold J, Bellone S, Manavell DD, Mutlu L, McNamara B, Hartwich TMP, Zipponi M, Yang-Hartwich Y, Demirkiran C, Verzosa MSZ, Choi J, Dong W, Buza N, Hui P, Altwerger G, Huang GS, Andikyan V, Clark M, Ratner E, Azodi M, Schwartz PE, Santin AD.
Harold J, et al. Among authors: andikyan v.
Gynecol Oncol. 2023 Mar;170:334. doi: 10.1016/j.ygyno.2023.01.029.
Gynecol Oncol. 2023.
PMID: 36906375
Free PMC article.
No abstract available.